METHOD FOR PREPARING A VACCINE COMPOSITION COMPRISING AT LEAST ONE ANTIGEN AND AT LEAST ONE ADJUVANT
    2.
    发明申请
    METHOD FOR PREPARING A VACCINE COMPOSITION COMPRISING AT LEAST ONE ANTIGEN AND AT LEAST ONE ADJUVANT 有权
    用于制备包含至少一种抗原和至少一种调节剂的疫苗组合物的方法

    公开(公告)号:US20100233196A1

    公开(公告)日:2010-09-16

    申请号:US12739389

    申请日:2008-10-06

    IPC分类号: A61K39/00 A61P37/04

    摘要: Method for preparing a vaccine, comprising—a step a) of preparing an adjuvant composition by dispersing, in a physiologically acceptable aqueous solution, at least one inverse latex or a powder of polymer resulting from the atomization of said inverse latex; —a step b) of mixing the composition obtained in step a) into an antigenic medium, intended to form a vaccine composition.

    摘要翻译: 制备疫苗的方法,包括:a)通过在生理上可接受的水溶液中分散至少一种反相胶乳或由所述反相胶乳的雾化产生的聚合物粉末来制备佐剂组合物; - 步骤b)将步骤a)中获得的组合物混合到用于形成疫苗组合物的抗原介质中。

    NOVEL THICKENING POLYMER IN THE FORM OF A POWDER
    7.
    发明申请
    NOVEL THICKENING POLYMER IN THE FORM OF A POWDER 审中-公开
    粉末形式的新型增稠聚合物

    公开(公告)号:US20120095120A1

    公开(公告)日:2012-04-19

    申请号:US13318855

    申请日:2010-03-30

    IPC分类号: B01J39/20

    摘要: Method for preparing an anionic polyelectrolyte including up to 95 mol % of monomer units from 2-methyl 2-[(1-oxo 2-propenyl) amino] 1-propanesulfonic acid that is totally salified in the form of sodium salt, up to 90 mol % of at least one neutral monomer, and optionally up to 10 mol % of at least one monomer of formula (I): where: R1 is a hydrogen atom or a methyl radical, R is an alkyl radical, and n is a number greater than or equal to 1 and less than or equal to 50, the method including: a) preparing a reaction mixture containing, in a solvent (S), 2-methyl 2-[(1-oxo 2-propenyl) amino] 1-propanesulfonic acid, the neutral monomer(s), the neutralizing agent, and optionally, the monomer(s) of formula (I); and b) polymerizing the reaction mixture. The polyelectrolyte can be used as a thickening and/or stabilizing and/or emulsifying agent for a cosmetic, dermopharmaceutical or pharmaceutical topical composition.

    摘要翻译: 从钠盐形式完全盐化的2 - [(1-氧代-2-丙烯基)氨基] -1-丙磺酸的2-甲基的制备阴离子聚电解质的方法,该阴离子聚电解质包含至多95摩尔%的单体单元, 至少一种中性单体的摩尔%,和任选的至多10摩尔%的至少一种式(I)的单体:其中:R1是氢原子或甲基,R是烷基,n是数 大于或等于1且小于或等于50,该方法包括:a)制备在溶剂(S)中含有2 - [(1-氧代-2-丙烯基)氨基] 1 - 丙烷磺酸,中性单体,中和剂和任选的式(I)的单体; 和b)使反应混合物聚合。 聚电解质可用作化妆品,皮肤药物或药物局部组合物的增稠和/或稳定和/或乳化剂。